NOVERA RETATRUTIDE: THE NEW APPROACH FOR WEIGHT CONTROL?

Emerging clinical evidence suggests that Novera Retatrutide, a dual-action medication from Novo Nordisk, could provide a meaningful step in body management. Unlike many existing treatments, Retatrutide affects both GLP-1 and GIP, potentially resulting to improved losses in fat and more favorable